Townsend & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
+11,695
| New | +$2.23M | 0.22% | 50 |
|
|
2022
Q2 | – | Sell |
-13,747
| Closed | -$2.41M | – | 79 |
|
|
2022
Q1 | $2.41M | Buy |
13,747
+1,074
| +8% | +$188K | 1.11% | 29 |
|
|
2021
Q4 | $1.72M | Buy |
+12,673
| New | +$1.72M | 0.94% | 45 |
|
|
2018
Q4 | – | Sell |
-12,147
| Closed | -$1.15M | – | 72 |
|
|
2018
Q3 | $1.15M | Buy |
12,147
+2,482
| +26% | +$235K | 1.14% | 34 |
|
|
2018
Q2 | $895K | Buy |
9,665
+665
| +7% | +$61.6K | 1% | 37 |
|
|
2018
Q1 | $852K | Buy |
9,000
+891
| +11% | +$84.3K | 0.68% | 33 |
|
|
2017
Q4 | $784K | Buy |
+8,109
| New | +$784K | 0.67% | 40 |
|